ANP32A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.760200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.108000E-01
Normal-vs-Stage2
3.444400E-01
Normal-vs-Stage3
2.617600E-01
Normal-vs-Stage4
1.160390E-01
Stage1-vs-Stage2
8.686000E-01
Stage1-vs-Stage3
3.805000E-01
Stage1-vs-Stage4
3.792800E-01
Stage2-vs-Stage3
3.042200E-01
Stage2-vs-Stage4
5.145400E-01
Stage3-vs-Stage4
7.791600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.248400E-01
Normal-vs-AfricanAmerican
5.013900E-02
Normal-vs-Asian
2.221600E-01
Caucasian-vs-AfricanAmerican
6.496100E-02
Caucasian-vs-Asian
3.317000E-01
AfricanAmerican-vs-Asian
8.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.797200E-01
Normal-vs-Female
3.898800E-01
Male-vs-Female
8.699000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.198600E-01
Normal-vs-Age(41-60Yrs)
3.758600E-01
Normal-vs-Age(61-80Yrs)
3.408600E-01
Normal-vs-Age(81-100Yrs)
7.317400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.236000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.316600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.947000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.672810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.714400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.933230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.630600E-01
Normal-vs-Daily Drinker
3.766000E-01
Normal-vs-Weekly Drinker
8.607800E-02
Normal-vs-Occasional Drinker
9.728600E-01
Normal-vs-Social Drinker
1.617190E-01
Non Drinker-vs-Daily Drinker
8.897600E-01
Non Drinker-vs-Weekly Drinker
1.919800E-01
Non Drinker-vs-Occasional Drinker
1.691550E-01
Non Drinker-vs-Social Drinker
5.863400E-01
Daily Drinker-vs-Weekly Drinker
2.888800E-01
Daily Drinker-vs-Occasional Drinker
1.458390E-01
Daily Drinker-vs-Social Drinker
7.135200E-01
Weekly Drinker-vs-Occasional Drinker
2.880200E-02
Weekly Drinker-vs-Social Drinker
4.134400E-01
Occasional Drinker-vs-Social Drinker
8.701600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.325800E-01
Normal-vs-Grade 2
5.789000E-01
Normal-vs-Grade 3
5.127500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.079800E-01
Grade 1-vs-Grade 3
2.764400E-01
Grade 1-vs-Grade 4
3.325800E-01
Grade 2-vs-Grade 3
1.432620E-01
Grade 2-vs-Grade 4
5.789000E-01
Grade 3-vs-Grade 4
5.127500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.824400E-01
Normal-vs-NonDiabetic
4.258400E-01
Diabetic-vs-NonDiabetic
5.255000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.729200E-01
Normal-vs-NoPancreatitis
4.080200E-01
Pancreatitis-vs-NoPancreatitis
6.635200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.619800E-01
Normal-vs-N1
3.795200E-01
N0-vs-N1
9.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.049800E-01
Normal-vs-TP53-NonMutant
3.515400E-01
TP53-Mutant-vs-TP53-NonMutant
1.365570E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
